Navigation Links
California Healthcare Institute Appoints Vice President-State Government Affairs

LA JOLLA, Calif. (PRWEB) March 11, 2013

The California Healthcare Institute (CHI) announced today the appointment of Eve Bukowski as vice president of state government affairs based in CHI’s Sacramento Office. CHI is a non-profit public policy research and advocacy organization for California’s biomedical R&D industry.

As CHI’s vice president of state government affairs, Bukowski is responsible for managing CHI's Sacramento office, where she directs the organization's state government relations advocacy and outreach activities across a range of issues, including implementation of the Affordable Care Act, tax issues, education and workforce development and environmental regulation.

“As our economy continues to recover, it is crucial that California’s biomedical community has strong representation in Sacramento,” said CHI President and CEO David L. Gollaher, Ph.D. “Eve brings a wealth of experience in government affairs and legislative advocacy, enabling CHI to build and maintain strong ties with legislators and the governor, while fostering exceptional member relations. I am delighted to welcome her to CHI.”

Bukowski most recently served as executive director for TechNet, a trade association representing biotechnology, clean technology, high-tech, venture capital firms and social media companies. During her tenure, she was responsible for developing and implementing TechNet’s legislative agenda and strategy. In this capacity, Eve developed strong relationships with leading policymakers, advocating and advancing key issues of importance to the industry before the state Legislature, administration and agencies on behalf of TechNet. Prior to her work there, Bukowski served as the government affairs manager at the Port of Oakland, where she directed all Port interaction with federal, state and local government officials. Bukowski is a member of the California State Bar, and holds a law degree from the UC Davis School of Law and bachelor’s degree in government from Pomona College.

About CHI
CHI represents more than 275 leading biotechnology, medical device, diagnostics, and pharmaceutical companies, and public and private academic biomedical research organizations. CHI’s mission is to advance responsible public policies that foster medical innovation and promote scientific discovery. CHI’s website is Follow us on Twitter, Facebook, LinkedIn and YouTube.

Editorial note: Photo available upon request.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Synteract and MediciNova Partner in "Fight For Air Walk" to Support the American Lung Association in California
2. The Law Firm of Levi & Korsinsky, LLP Launches an Investigation Into Possible Securities Laws Violations by Pacific Biosciences of California, Inc.
3. Epitomics, Inc. and University of California, Davis, Complete Star Program for High-Throughput Measurement of Antibody-Antigen Interactions
4. Agendia Signs Contract with Blue Shield of California
5. Intellect Neurosciences Enters Collaboration Agreement with Leading Alzheimers Research Group at University of California Irvine to Test First in Class Dual Target Vaccine
6. Synthetic Genomics Inc. Purchases 81 Acre Site in South California Desert for Scale up and Testing of Innovative Algae Strains
7. Pacific BioStorage Announces an Exciting New First for The Life Sciences Industry in Southern California
8. Lightning Brewery’s Craft Beer Old Tempestuous Ale Wins Best of Show at 2012 California State Fair Commercial Brewing Competition
9. Californians Take One Step Closer to Directly Accessing Physical Therapy Services for Immediate Treatment
10. California Healthcare Institute Issues Statement on Supreme Court Ruling on the Affordable Care Act
11. California Physical Therapists Prediction Proved "Right" by Results of State Board Audit
Post Your Comments:
(Date:6/27/2016)... ... June 27, 2016 , ... ... on what they believe could be a new and helpful biomarker for malignant ... Click here to read it now. , Biomarkers are components in ...
(Date:6/27/2016)... 2016  Liquid Biotech USA ... a Sponsored Research Agreement with The University of ... from cancer patients.  The funding will be used ... with clinical outcomes in cancer patients undergoing a ... be employed to support the design of a ...
(Date:6/24/2016)... ... 2016 , ... While the majority of commercial spectrophotometers and fluorometers use the ... models are higher end machines that use the more unconventional z-dimension of 20mm. ... the bottom of the cuvette holder. , FireflySci has developed several Agilent flow ...
(Date:6/23/2016)... June 23, 2016   Boston Biomedical , ... compounds designed to target cancer stemness pathways, announced ... granted Orphan Drug Designation from the U.S. Food ... gastric cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin ... to inhibit cancer stemness pathways by targeting STAT3, ...
Breaking Biology Technology:
(Date:4/15/2016)... , April 15, 2016 ... "Global Gait Biometrics Market 2016-2020,"  report to their ... ) , ,The global gait biometrics market ... 13.98% during the period 2016-2020. Gait ... which can be used to compute factors that ...
(Date:3/31/2016)... 31, 2016  Genomics firm Nabsys has completed a ... Barrett Bready , M.D., who returned to the company ... technical leadership team, including Chief Technology Officer, John ... Steve Nurnberg and Vice President of Software and Informatics, ... Dr. Bready served as CEO of Nabsys ...
(Date:3/22/2016)... OTTAWA, Ontario , PROVO ... 2016 Newborn Screening Ontario (NSO), which operates ... for molecular testing, and Tute Genomics and ... process management technology respectively, today announced the launch of ... new next-generation sequencing (NGS) testing panel. ...
Breaking Biology News(10 mins):